AGREEMENTNeorx Corp • May 10th, 2004 • In vitro & in vivo diagnostic substances • Washington
This Agreement is entered into and made effective as of April 2, 2004, between NeoRx Corporation (“NeoRx”), having offices at 300 Elliott Avenue W., Suite 500, Seattle, Washington 98119-4114, and Aletheon Pharmaceuticals, Inc. (“Aletheon”), having offices at 2722 Triton Drive NW, Seattle, WA 98117.
SUPPLY AGREEMENTSupply Agreement • May 10th, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
This agreement (the “Agreement”) is entered into effective as of March 1, 2004 by and between The Curators of The University of Missouri, a public corporation of the State of Missouri, contracting on behalf of its Research Reactor Center, University of Missouri-Columbia (hereafter “University”), and NeoRx Corporation, a Washington corporation (“NeoRx”). University and NeoRx may hereafter from time to time be referred to collectively as the “Parties” and individually as a “Party.”
ANORMED INC. AND NEORX CORPORATIONLicense Agreement • May 10th, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances • Washington
THIS LICENSE AGREEMENT (this “Agreement”) is entered into as of , 2004 (the “Effective Date”) by and among ANORMED INC. (“AnorMED”), a corporation organized and existing under the laws of Canada and having an office at #200 - 20353 64th Ave, Langley, BC Canada V2Y 1N5 and NEORX CORPORATION (“NeoRx”), a corporation organized and existing under the laws of the State of Washington, United States of America, and having an office at 300 Elliott Avenue West, Suite 500, Seattle, Washington, USA 98119-4114.
